Stability Indicating LC Method Development for Hydroxychloroquine Sulfate Impurities as Available for Treatment of COVID-19 and Evaluation of Risk Assessment Prior to Method Validation by Quality by Design Approach.

Dongala, Thirupathi; Katari, Naresh Kumar; Palakurthi, Ashok Kumar; Katakam, Lakshmi Narasimha Rao; Marisetti, Vishnu Murthy

Dongala, Thirupathi; Katari, Naresh Kumar; Palakurthi, Ashok Kumar; Katakam, Lakshmi Narasimha Rao; Marisetti, Vishnu Murthy.

Afiliação

Dongala T; Analytical Research and Development, Aurex Laboratories LLC, 10 lake drive, East windsor, New Jersey 08520 USA.
Katari NK; Department of Chemistry, GITAM University, Hyderabad, Telangana 502329 India.
Palakurthi AK; Department of Chemistry, GITAM University, Hyderabad, Telangana 502329 India.
Katakam LNR; Analytical Research and Development, Aurex Laboratories LLC, 10 lake drive, East windsor, New Jersey 08520 USA.
Marisetti VM; Analytical Development, Saptalis Pharmaceuticals LLC, Hauppauge, NY 11788 USA.

Chromatographia ; 83(10): 1269-1281, 2020.

Article em En | MEDLINE | ID: mdl-32863397

Palavras-chave

Design of experiments; HPLC; Hydroxychloroquine sulfate; Quality by design; Validation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google